HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial.

AbstractOBJECTIVE:
To compare a short course of antibiotics (48 to 96 hours) and a standard course of antibiotics (7 days) for probable neonatal sepsis.
DESIGN:
Randomized, controlled, open-labeled trial with blocking and stratification according to birth weight.
SETTING:
Tertiary care, referral, teaching hospital in Northern India.
PARTICIPANTS:
Neonates >30 wks gestation and >1000 g at birth, with probable sepsis (clinical signs of sepsis, raised C reactive protein) were enrolled. Babies with major malformations, severe birth asphyxia, meningitis, bone or joint or deep-seated infection, those who were already on antibiotics, and those undergoing surgery were excluded. Neonates, who had clinically remitted on antibiotic therapy by the time a sterile blood culture report was received were randomized.
INTERVENTION:
In the intervention arm, antibiotics were stopped after the 48 hour culture was reported sterile. In the control arm, antibiotics were continued to a total of 7 days.
MAIN OUTCOME MEASURE:
Treatment failure defined as reappearance of signs suggestive of sepsis within 15 days of stopping antibiotics, supported by laboratory evidence and adjudicated by a blinded expert committee.
RESULTS:
52 neonates were randomized to receive a short course or 7 day course (n=26 each). Baseline variables were balanced in the 2 groups. There was no significant difference in the treatment failures between the 2 groups (3 babies in the 7-day group vs none in short course group, P=0.23).
CONCLUSION:
No difference in the treatment failure rates could be identified between short course and 7-day groups among neonates >30 weeks and > 1000 grams with probable sepsis.
AuthorsShiv Sajan Saini, Sourabh Dutta, Pallab Ray, Anil Narang
JournalIndian pediatrics (Indian Pediatr) Vol. 48 Issue 1 Pg. 19-24 (Jan 2011) ISSN: 0974-7559 [Electronic] India
PMID20972299 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (administration & dosage)
  • Bacteremia (drug therapy, microbiology)
  • Chi-Square Distribution
  • Drug Administration Schedule
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases (drug therapy, microbiology)
  • Injections, Intravenous
  • Pilot Projects
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: